A detailed history of Lynx Investment Advisory transactions in Pfizer Inc stock. As of the latest transaction made, Lynx Investment Advisory holds 27,295 shares of PFE stock, worth $703,392. This represents 0.57% of its overall portfolio holdings.

Number of Shares
27,295
Previous 27,456 0.59%
Holding current value
$703,392
Previous $768 Million 2.83%
% of portfolio
0.57%
Previous 0.57%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$27.7 - $31.39 $4,459 - $5,053
-161 Reduced 0.59%
27,295 $790 Million
Q2 2024

Jul 09, 2024

BUY
$25.26 - $29.6 $693,538 - $812,697
27,456 New
27,456 $768 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lynx Investment Advisory Portfolio

Follow Lynx Investment Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynx Investment Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Lynx Investment Advisory with notifications on news.